Bucks County Family Returns Home After Climbing Mt. Kilimanjaro to Raise Awareness About Ovarian Cancer CBS News News | Sep 21, 2023 After battling and overcoming ovarian cancer, Christine Hussey is no stranger to climbing mountains - literally! Christine made a goal of climbing Mount Kilimanjaro with her husband and twin sons to raise awareness for those affect by the disease. Latest News Folding@home: How You, and Your Computer, Can Play Scientist Penn Medicine News News | May 2023 Gregory Bowman, PhD hopes to uncover how to drug proteins related to the BRCA1 and BRCA2 genes which, when mutated, can lead to breast, ovarian, prostate, and pancreatic cancers. Six Warning Signs of Ovarian Cancer Daily Mail News | May 2023 “Ovarian cancer is often said to be a silent killer because it doesn’t have early symptoms, when in fact it does have symptoms, they’re just very general and could be caused by other things,” explained Ronny Drapkin, MD, PhD, director of the Ovarian Cancer Research Center, and Gynecologic Cancer Research, in the Basser Center for BRCA. New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023 A new study found that allowing a break in hormone suppression therapy to allow breast cancer survivors the chance to get pregnant and breastfeed did not appear to increase the risk of cancer recurring. Susan M. Domchek, MD, executive director of the Basser Center, who was not involved in the study, described the findings as “a gift we can give our patients." BRCA Mutations in Men: Three Things to Know Penn Medicine News News | May 2023 Learn what men should know about BRCA gene mutations from Kara Maxwell, MD, PhD, director of the Men & BRCA Program at the Basser Center for BRCA. AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023 During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, reviewed significant highlights and important themes from the meeting. “We have made progress and we have a lot more to do,” he said. Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023 Gregory R. Bowman, PhD, the first researcher funded by the Basser Cancer Interception Institute (BCII) and Professor of Biochemistry & Biophysics and Bioengineering, shared his team’s work using a neural network to find hidden pockets in proteins that could potentially be targeted with drugs to treat cancer. Broadening Cancer Screening with Whole-Exome Sequencing Cancer Discovery News | April 2023 A retrospective analysis presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting showed that whole-exome sequencing is an effective tool to identify people with hereditary cancer-predisposing conditions who would not meet current criteria for preventive screening. Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023 Penn Medicine has cemented its identity as a place that incubates and brings to life some of the most transformative modern medical advancements. Science has shifted toward more discoveries based on the underlying mechanism of disease, especially in new cancer drug discovery. AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023 “From cutting-edge basic science and translational science all the way into population science, we’re going to learn about trial results that will change practice,” Robert H. Vonderheide, MD, DPhil, director of the Penn Medicine Abramson Cancer Center said. Breakthroughs, Practice-Changing Data Expected at AACR 2023 Oncology Business Review News | April 2023 Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, explained, “This conference [AACR 2023] is about new ideas, new progress, and new findings. We have already made so much progress in cancer research, but it has only just begun.” Penn Medicine at the AACR Annual Meeting 2023 Penn Medicine News News | April 2023 Penn Medicine researchers will present four plenary sessions at the AACR – including remarks from the 2023 Annual Meeting Program Committee Chair Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center. Abramson Cancer Center Leader Outlines Immunotherapy Advances AACR Journals: Cancer Discovery News | April 2023 Researchers and oncologists have long looked to the body’s own defenses as a possible tool to conquer cancer. “We need to look at cancer vaccines to prevent disease or prevent relapse — to intercept cancer,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center. Vonderheide also provided a glimpse of some of the groundbreaking research to be presented at the event. Educated Patient Breast Cancer Summit at MBCC Precision Medicine Panel CURE News | March 2023 Basser Center executive director Dr. Susan Domchek participated in a panel discussion about precision medicine at the CURE Educated Patient Breast Cancer Summit. Program Covers the Hottest Topics in Cancer Research AACR News | March 2023 AACR Program Committee Chair Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center is excited for the topics that will be covered at the AACR Annual Meeting in 2023. The 2023 Health Care Power 100 City & State News | March 2023 City & State’s 2023 Health Care Power 100 highlights Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center, on framing, influencing, and trying to change the conversation around health care in Pennsylvania. Discussing Genetic Testing and Precision Medicine for Cancer CURE News | March 2023 As genetic testing becomes more available — and affordable — for patients with cancer, it is essential to discuss results with health care teams to better understand the significance, Susan M. Domchek, MD, executive director of the Basser Center for BRCA, explained during a presentation at the CURE Educated Patient Breast Cancer Summit. The Importance of Germline Testing in Breast Cancer Care OncLive.com News | March 2023 Susan M. Domchek, MD, executive director of the Basser Center for BRCA, discussed the importance of germline testing in breast cancer care. Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed Penn Medicine News News | March 2023 Up to 50% of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Gregory R. Bowman, PhD, a Penn professor of Biochemistry and Biophysics and Bioengineering, leads this study as the first researcher funded by the Basser Cancer Interception Institute (BCII). His grant from the BCII supports the application of his ongoing work to BRCA-related research. Pagination First page« First Previous page‹‹ Page1 Current page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
Bucks County Family Returns Home After Climbing Mt. Kilimanjaro to Raise Awareness About Ovarian Cancer CBS News News | Sep 21, 2023 After battling and overcoming ovarian cancer, Christine Hussey is no stranger to climbing mountains - literally! Christine made a goal of climbing Mount Kilimanjaro with her husband and twin sons to raise awareness for those affect by the disease.
Folding@home: How You, and Your Computer, Can Play Scientist Penn Medicine News News | May 2023 Gregory Bowman, PhD hopes to uncover how to drug proteins related to the BRCA1 and BRCA2 genes which, when mutated, can lead to breast, ovarian, prostate, and pancreatic cancers.
Six Warning Signs of Ovarian Cancer Daily Mail News | May 2023 “Ovarian cancer is often said to be a silent killer because it doesn’t have early symptoms, when in fact it does have symptoms, they’re just very general and could be caused by other things,” explained Ronny Drapkin, MD, PhD, director of the Ovarian Cancer Research Center, and Gynecologic Cancer Research, in the Basser Center for BRCA.
New Hope for Breast Cancer Survivors: Study Finds a Break in Hormone Suppression Therapy to Bear Children Is Relatively Safe Boston Globe News | May 2023 A new study found that allowing a break in hormone suppression therapy to allow breast cancer survivors the chance to get pregnant and breastfeed did not appear to increase the risk of cancer recurring. Susan M. Domchek, MD, executive director of the Basser Center, who was not involved in the study, described the findings as “a gift we can give our patients."
BRCA Mutations in Men: Three Things to Know Penn Medicine News News | May 2023 Learn what men should know about BRCA gene mutations from Kara Maxwell, MD, PhD, director of the Men & BRCA Program at the Basser Center for BRCA.
AACR Annual Meeting Highlights Showcased in Final Plenary Session American Association for Cancer Research News | April 2023 During the final session of the AACR Annual Meeting 2023, Program Committee Chair Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, reviewed significant highlights and important themes from the meeting. “We have made progress and we have a lot more to do,” he said.
Next-Generation Cancer Therapies Will Reshape Cancer Treatment in the Coming Years American Association for Cancer Research News | April 2023 Gregory R. Bowman, PhD, the first researcher funded by the Basser Cancer Interception Institute (BCII) and Professor of Biochemistry & Biophysics and Bioengineering, shared his team’s work using a neural network to find hidden pockets in proteins that could potentially be targeted with drugs to treat cancer.
Broadening Cancer Screening with Whole-Exome Sequencing Cancer Discovery News | April 2023 A retrospective analysis presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting showed that whole-exome sequencing is an effective tool to identify people with hereditary cancer-predisposing conditions who would not meet current criteria for preventive screening.
Making What’s Next in Medicine: Why Research at Penn Powers Many FDA-Approved Treatments Penn Medicine News News | April 2023 Penn Medicine has cemented its identity as a place that incubates and brings to life some of the most transformative modern medical advancements. Science has shifted toward more discoveries based on the underlying mechanism of disease, especially in new cancer drug discovery.
AACR Annual Meeting 2023 Overview: Advancing the Frontiers of Cancer Science and Medicine American Association of Cancer Research News | April 2023 “From cutting-edge basic science and translational science all the way into population science, we’re going to learn about trial results that will change practice,” Robert H. Vonderheide, MD, DPhil, director of the Penn Medicine Abramson Cancer Center said.
Breakthroughs, Practice-Changing Data Expected at AACR 2023 Oncology Business Review News | April 2023 Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, explained, “This conference [AACR 2023] is about new ideas, new progress, and new findings. We have already made so much progress in cancer research, but it has only just begun.”
Penn Medicine at the AACR Annual Meeting 2023 Penn Medicine News News | April 2023 Penn Medicine researchers will present four plenary sessions at the AACR – including remarks from the 2023 Annual Meeting Program Committee Chair Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center.
Abramson Cancer Center Leader Outlines Immunotherapy Advances AACR Journals: Cancer Discovery News | April 2023 Researchers and oncologists have long looked to the body’s own defenses as a possible tool to conquer cancer. “We need to look at cancer vaccines to prevent disease or prevent relapse — to intercept cancer,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center. Vonderheide also provided a glimpse of some of the groundbreaking research to be presented at the event.
Educated Patient Breast Cancer Summit at MBCC Precision Medicine Panel CURE News | March 2023 Basser Center executive director Dr. Susan Domchek participated in a panel discussion about precision medicine at the CURE Educated Patient Breast Cancer Summit.
Program Covers the Hottest Topics in Cancer Research AACR News | March 2023 AACR Program Committee Chair Robert H. Vonderheide, MD, DPhil, Director of the Abramson Cancer Center is excited for the topics that will be covered at the AACR Annual Meeting in 2023.
The 2023 Health Care Power 100 City & State News | March 2023 City & State’s 2023 Health Care Power 100 highlights Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center, on framing, influencing, and trying to change the conversation around health care in Pennsylvania.
Discussing Genetic Testing and Precision Medicine for Cancer CURE News | March 2023 As genetic testing becomes more available — and affordable — for patients with cancer, it is essential to discuss results with health care teams to better understand the significance, Susan M. Domchek, MD, executive director of the Basser Center for BRCA, explained during a presentation at the CURE Educated Patient Breast Cancer Summit.
The Importance of Germline Testing in Breast Cancer Care OncLive.com News | March 2023 Susan M. Domchek, MD, executive director of the Basser Center for BRCA, discussed the importance of germline testing in breast cancer care.
Penn Medicine Research Suggests More Cancers Can Be Treated with Drugs Than Previously Believed Penn Medicine News News | March 2023 Up to 50% of cancer-signaling proteins once believed to be immune to drug treatments due to a lack of targetable protein regions may actually be treatable, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Gregory R. Bowman, PhD, a Penn professor of Biochemistry and Biophysics and Bioengineering, leads this study as the first researcher funded by the Basser Cancer Interception Institute (BCII). His grant from the BCII supports the application of his ongoing work to BRCA-related research.
